Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

AZOPT 1% EYE DROPS

brinzolamide
$35.1697per ML
Discontinued

Strength

10 mg/mL

Manufacturer

Novartis Pharmaceuticals Corporation

NDC

00078072210

Classification

Brand

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Last Updated

2/18/2026

Active Ingredients

BRINZOLAMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA020816

On Market Since

4/30/1998

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

+0.0%

6M

+0.0%

1Y

-0.4%

3Y

+2.0%

5Y

N/A

All

+6.8%

Generic Alternatives

Save up to 71%

4 alternatives • Same active ingredient

BRINZOLAMIDE 1% EYE DROPS
Generic
24208046415•Bausch & Lomb Incorporated
$10.0825
Save 71%
BRINZOLAMIDE 1% EYE DROPS
Generic
00574401215•Padagis US LLC
$10.0825
Save 71%
BRINZOLAMIDE 1% EYE DROPS
Generic
68682046410•Oceanside Pharmaceuticals
$10.3789
Save 70%
AZOPT 1% EYE DROPS
Brand
66758008570•Sandoz Inc.
$35.1442
Save 0%

Related Drugs

Same classification

ZONISADE 100 MG/5 ML ORAL SUSP
Brand
52652800101•Azurity Pharmaceuticals Inc.
$2.7530
per ML
COSOPT PF EYE DROPS
Brand
82584060430•Thea Pharma Inc.
$3.3006
per EA
ZONEGRAN 25 MG CAPSULE
Brand
59212068110•Advanz Pharma (US) Corp.
$12.3123
per EA
ZONEGRAN 100 MG CAPSULE
Brand
59212068010•Advanz Pharma (US) Corp.
$15.3102
per EA
COSOPT EYE DROPS
Brand
82584060510•Thea Pharma Inc.
$23.1695
per ML
SIMBRINZA 1%-0.2% EYE DROP
Brand
00065414727•Alcon Laboratories, Inc.
$26.0684
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy